This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
search
BIO-Europe Spring Interviews

Oncology Venture differentiates using big data systems biology

Posted by on 15 March 2018
Share this article

With six oncology assets in Phase II/III ready for outlicensing, Oncology Venture is now looking to take additional programs on board. Speaking to Scrip at BIO-Europe Spring 2018 in Amsterdam, co-founder and CEO Peter Buhl Jensen explains how the company identifies opportunities.

Share this article

Related Articles

Biotech Showcase™ 2019

China Bio: Change and opportunity are constant

Read More
east
Read More
east
Biotech Showcase™ 2020

What's shaping the future of biotech?

Read More
east
Read More
east
View all related articleseast

Related Event

Biotech Showcase

  • 8 Jan, 2024
  • 3 days
  • January 13–15, 2025

Sign up for Partnering, Business Development & Licensing email updates

keyboard_arrow_down
Subscribeeast